ENDO PHARM HLDGS I ENDP (NASDAQ) $ 20.07 Change: +0.1 +0.5% | Volume: 1,759,126
Sponsored by Click here!

ENDO PHARMACEUT - Fundamental Profile

Company Information

Ticker Symbol: ENDP
Exchange: NASD
Contact Info: 100 Endo Boulevard Chadds Ford PA 19317 610-558-9800
CEO/President: Peter A. Lankau
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Endo Pharmaceuticals Holdings Inc., through its wholly owned subsidiaries, Endo Pharmaceuticals Inc. and Endo Inc., is engaged in the research, development, sales and marketing of branded and generic prescription pharmaceuticals used primarily for the treatment and management of pain.

Share Information

Shares Outstanding: 120,290 (000) Market Value: 2,376,910 ($000)
Percentage of Inst.Shareholders: 97.17% Number of Inst.Shareholders: 2.00%
Last Quarter Sales: 316.77 ($Mil.) Last Quarter Net Income: 68.25 ($Mil.)
Last Quarter EPS: 0.61 P/E Ratio: 9
Most Recent Earnings: 0.64 on 10/30/08 Earnings Per Share: 1.87
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -30.30 15.83
JOHNSON AND JOH -16.60 57.92
BRISTOL MYERS S -24.70 19.55
SCHERING PLOUGH -48.10 14.63
MERCK CO INC -54.30 26.72